RESPIRATORY INFECTIONS IN PATIENTS UNDERGOING FIRST-LINE BIOLOGIC THERAPY FOR RHEUMATOID ARTHRITIS

被引:0
|
作者
Nakamoto, Keitaro [1 ]
Saraya, Takeshi [1 ]
Sada, Mitsuru [1 ]
Inui, Toshiya [1 ]
Ogawa, Yukari [1 ]
Koide, Takashi [1 ]
Takata, Saori [1 ]
Watanabe, Masato [1 ]
Yokoyama, Takuma [1 ]
Kurai, Daisuke [1 ]
Ishii, Haruyuki [1 ]
Takizawa, Hajime [1 ]
机构
[1] Kyorin Univ, Sch Med, Dept Resp Med, Tokyo, Japan
关键词
D O I
暂无
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
395
引用
收藏
页码:133 / 133
页数:1
相关论文
共 50 条
  • [41] BIOLOGIC THERAPY OPTIMIZATION IN RHEUMATOID ARTHRITIS PATIENTS IN COLOMBIA
    Rojas Zuleta, W. G.
    Felipe Diaz, O. J.
    Pantoja Marquez, A. E.
    Giraldo, R.
    Lopez Velandia, J. G.
    Navarro Mendoza, E. P.
    Orozco Gonzalez, C.
    Barbosa Camacho, J.
    Duque Zapata, N.
    Donado Gomez, J.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 1453 - 1454
  • [42] Switching Biologic Therapy in a Population of Rheumatoid Arthritis Patients
    Souza, Branca
    Valim, Juliana
    Chaer, Fernanda
    Guimaraes, Fernanda
    Lima, Veronica
    ARTHRITIS & RHEUMATOLOGY, 2016, 68
  • [43] Ulcerative Colitis Therapy: Vedolizumab as a First-line Biologic Agent?
    Metzger, Leandra
    ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2022, 60 (03): : 274 - 276
  • [44] Is rituximab suitable for use as a first-line biologic therapy for RA?
    Kleiner, Anatole
    Looney, R. John
    NATURE CLINICAL PRACTICE RHEUMATOLOGY, 2008, 4 (11): : 574 - 575
  • [45] Is rituximab suitable for use as a first-line biologic therapy for RA?
    Anatole Kleiner
    R John Looney
    Nature Clinical Practice Rheumatology, 2008, 4 : 574 - 575
  • [46] Rheumatoid arthritis treated with 6-months of first-line biologic or biosimilar therapy: an updated systematic review and network meta-analysis
    Simpson, Emma L.
    Ren, Shijie
    Hock, Emma S.
    Stevens, John W.
    Binard, Aymeric
    Pers, Yves-Marie
    Archer, Rachel
    Paisley, Suzy
    Stevenson, Matthew D.
    Herpin, Chloe
    Ghabri, Salah
    INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 2019, 35 (01) : 36 - 44
  • [47] First-line biologic therapy with tumor necrosis factor inhibitors for psoriatic arthritis: a prospective observational study
    da SilvaI, Michael Ruberson Ribeiro
    dos Santos, Jessica Barreto Ribeiro
    Kakehasi, Adriana Maria
    Almeida, Alessandra Maciel
    Pimenta, Pedro Ricardo Komel
    Alvares-Teodoro, Juliana
    Acurcio, Francisco de Assis
    SAO PAULO MEDICAL JOURNAL, 2022, 140 (06): : 787 - 797
  • [48] Infections in Patients With Rheumatoid Arthritis Undergoing Anti-TNF alpha Drug Therapy
    Alonso Ruiz, Alberto
    REUMATOLOGIA CLINICA, 2008, 4 : 18 - 23
  • [49] Opportunistic infections in rheumatoid arthritis patients exposed to biologic therapy: results from the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis
    Rutherford, Andrew I.
    Patarata, Eunice
    Subesinghe, Sujith
    Hyrich, Kimme L.
    Galloway, James B.
    RHEUMATOLOGY, 2018, 57 (06) : 997 - 1001
  • [50] Empirical first-line antibioticotherapy in adult rural patients with acute respiratory tract infections
    Panasiuk, Lech
    Lukas, Witold
    Paprzycki, Piotr
    ANNALS OF AGRICULTURAL AND ENVIRONMENTAL MEDICINE, 2007, 14 (02) : 305 - 311